Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04634825
Brief Title: Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer

First Submitted : November 12, 2020
First Submitted that Met QC Criteria : November 12, 2020
First Posted : November 18, 2020

Last Update Submitted that Met QC Criteria : May 16, 2022
Last Update Posted : May 18, 2022